Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway

Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma incidences are more than 10% within the population. Most of the patients with osteosarcoma fall within the age of 15–30 years. Therefore, in this research, we examined the anticancer effect of Rhaponticin against the hum...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Saudi J Biol Sci
Hlavní autoři: Mickymaray, Suresh, Alfaiz, Faiz Abdulaziz, Paramasivam, Anand, Veeraraghavan, Vishnu Priya, Periadurai, Nanthini Devi, Surapaneni, Krishna Mohan, Niu, Guangfeng
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8241634/
https://ncbi.nlm.nih.gov/pubmed/34220214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2021.05.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky